Skip to main navigation Skip to search Skip to main content

CYP2C9 polymorphisms impair acenocoumarol metabolism, but do not increase bleeding risk.

  • JF van der Heijden
  • , S Schmits
  • , MGH Remkes
  • , BA Hutten
  • , PH Reitsma

Research output: Contribution to journalMeeting AbstractOther research output

Original languageEnglish
Pages (from-to)149A-149A
Number of pages1
JournalBlood
Volume100
Issue number11
Publication statusPublished - 16 Nov 2002
Event44th Annual Meeting of the American-Society-of-Hematology - PHILADELPHIA, Netherlands
Duration: 6 Dec 200210 Dec 2002

Cite this